Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.

Brinzevich D, Young GR, Sebra R, Ayllon J, Maio SM, Deikus G, Chen BK, Fernandez-Sesma A, Simon V, Mulder LC.

J Virol. 2014 Jun;88(11):6213-23. doi: 10.1128/JVI.00669-14. Epub 2014 Mar 19.

2.

HIV-1 Vif adaptation to human APOBEC3H haplotypes.

Ooms M, Brayton B, Letko M, Maio SM, Pilcher CD, Hecht FM, Barbour JD, Simon V.

Cell Host Microbe. 2013 Oct 16;14(4):411-21. doi: 10.1016/j.chom.2013.09.006.

3.

Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A.

Voorman RL, Maio SM, Payne NA, Zhao Z, Koeplinger KA, Wang X.

J Pharmacol Exp Ther. 1998 Oct;287(1):381-8.

PMID:
9765359
4.

Absorption, distribution, metabolism, and excretion of atevirdine in the rat.

Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Schuette MR, Judy RW, Voorman RL, Maio SM, Slatter JG.

Drug Metab Dispos. 1998 Oct;26(10):1008-18.

PMID:
9763407
6.

Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-life.

Batra JK, Kasturi S, Gallo MG, Voorman RL, Maio SM, Chaudhary VK, Pastan I.

Mol Immunol. 1993 Mar;30(4):379-86.

PMID:
8455638

Supplemental Content

Support Center